Clinical Trials Directory

Trials / Unknown

UnknownNCT05423028

Vitamin B12 and Dextrose for Median Nerve Hydrodissection

The Effects of Vitamin B12 and Dextrose on the Ultrasound-guided Median Nerve Hydrodissection

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
National Cheng-Kung University Hospital · Academic / Other
Sex
All
Age
20 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Carpal tunnel syndrome is the most common peripheral entrapment neuropathy of the upper limb. Previous experiments found that ultrasound-guided median nerve hydrodissection with 5% dextrose water could ameliorate the condition of carpal tunnel syndrome. Oral administration of vitamin B 12 had been reported to reduce the discomfort from peripheral neuropathy although the level of evidence is not strong. This prospective, double-blind randomized control trial aims to compare the effects of different kinds of the injection agents on carpal tunnel syndrome.

Conditions

Interventions

TypeNameDescription
PROCEDUREUltrasound-guided nerve hydrodissectionPeri- median nerve injection for hydrorelease and decompression

Timeline

Start date
2021-12-07
Primary completion
2024-12-01
Completion
2024-12-01
First posted
2022-06-21
Last updated
2024-03-21

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT05423028. Inclusion in this directory is not an endorsement.

Vitamin B12 and Dextrose for Median Nerve Hydrodissection (NCT05423028) · Clinical Trials Directory